BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24682682)

  • 1. Role of doxycycline in Clostridium difficile infection acquisition.
    Turner RB; Smith CB; Martello JL; Slain D
    Ann Pharmacother; 2014 Jun; 48(6):772-6. PubMed ID: 24682682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis.
    Tariq R; Cho J; Kapoor S; Orenstein R; Singh S; Pardi DS; Khanna S
    Clin Infect Dis; 2018 Feb; 66(4):514-522. PubMed ID: 29401273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia.
    O'Leary AL; Chan AK; Wattengel BA; Xu J; Mergenhagen KA
    Am J Infect Control; 2024 Mar; 52(3):280-283. PubMed ID: 37921728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
    Chia BY; Teo JQ; Lee W; Liew YX; Ee RP; Chlebicki MP; Oon LL; Kwa AL
    J Glob Antimicrob Resist; 2019 Jun; 17():312-315. PubMed ID: 30682564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice measures for controlling and preventing hospital associated Clostridium difficile infections.
    Ramai D; Noorani A; Ofosu A; Ofori E; Reddy M; Gasperino J
    Hosp Pract (1995); 2019 Aug; 47(3):123-129. PubMed ID: 31177865
    [No Abstract]   [Full Text] [Related]  

  • 6. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fidaxomicin for the treatment of Clostridium difficile infections.
    Whitman CB; Czosnowski QA
    Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
    Baur D; Gladstone BP; Burkert F; Carrara E; Foschi F; Döbele S; Tacconelli E
    Lancet Infect Dis; 2017 Sep; 17(9):990-1001. PubMed ID: 28629876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection.
    Sullivan KM; Spooner LM
    Ann Pharmacother; 2010 Feb; 44(2):352-9. PubMed ID: 20071495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis.
    Feazel LM; Malhotra A; Perencevich EN; Kaboli P; Diekema DJ; Schweizer ML
    J Antimicrob Chemother; 2014 Jul; 69(7):1748-54. PubMed ID: 24633207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bezlotoxumab for the Prevention of
    Chahine EB; Cho JC; Worley MV
    Consult Pharm; 2018 Feb; 33(2):89-97. PubMed ID: 29409575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
    Price J; Cheek E; Lippett S; Cubbon M; Gerding DN; Sambol SP; Citron DM; Llewelyn M
    Clin Microbiol Infect; 2010 Aug; 16(8):1297-302. PubMed ID: 19832710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection, treatment, and prevention of Clostridium difficile infection.
    McCollum DL; Rodriguez JM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):581-92. PubMed ID: 22433924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of improvement in antimicrobial prescribing after a diagnosis of Clostridium difficile and impact on recurrence.
    Watson RL; Graber CJ
    Am J Infect Control; 2018 Dec; 46(12):1370-1374. PubMed ID: 29779687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection.
    Roshan N; Hammer KA; Riley TV
    Anaerobe; 2018 Feb; 49():103-111. PubMed ID: 29309845
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Keeley AJ; Beeching NJ; Stott KE; Roberts P; Watson AJ; Beadsworth MB
    Malawi Med J; 2016 Jun; 28(2):66-69. PubMed ID: 27895832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile control measures: current and future methods for prevention.
    Mejia-Chew C; Dubberke ER
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines.
    Gerding DN
    Discov Med; 2012 Jan; 13(68):75-83. PubMed ID: 22284786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital management of Clostridium difficile infection: a review of the literature.
    Khanafer N; Voirin N; Barbut F; Kuijper E; Vanhems P
    J Hosp Infect; 2015 Jun; 90(2):91-101. PubMed ID: 25913648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
    Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
    J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.